D-Wave’s Bipolar Week: Revenue Crashes, Bookings Soar, and the Government Buys In

D-Wave stock jumps after US Commerce Dept agreement for $100M equity injection. Q1 revenue slumps to $2.86M, net loss triples, but Washington backing and dilution trade-off spark rally.

D-Wave Quantum has spent the past few days straddling two entirely different realities. One is a Washington-backed future where a $100 million equity injection from the US government validates its quantum computing roadmap. The other is a profoundly messy present: first-quarter revenue collapsed to $2.86 million from $15.0 million a year earlier, and the net loss ballooned to $18.4 million from $5.4 million. The stock market chose to focus on the former, sending shares up roughly 44% on the week.

The catalyst was a non-binding letter of intent signed with the US Department of Commerce under the CHIPS and Science Act. The structure is what sets this apart from a conventional grant. D-Wave will not repay the $100 million in cash; instead, it will issue an equivalent amount of new shares to the government, making the Commerce Department a direct equity holder. The funding is earmarked for a new research facility in Boca Raton, Florida, as well as existing centers in Connecticut and British Columbia. The stated goals are an annealing system with 100,000 qubits and a gate-model system with 10,000 physical qubits — roughly 100 logical qubits, the threshold many consider necessary for commercial viability.

The market responded in two surges. On Thursday, the day of the announcement, shares jumped more than 33%. Friday added another 13.6%, closing at €25.04. Trading volume hit around 140 million shares on Friday alone, roughly three-and-a-half times the 30-day average. Despite the rally, the stock remains about 35% below its 52-week high of €38.48, and the 14-day relative strength index sits at 47 — a neutral reading that suggests the move may have further room to run before becoming overbought.

Dilution Is the Price of Legitimacy

Equity issuance to the government is not a footnote; it is the deal’s central feature. The number of D-Wave shares outstanding has already risen 226% since the start of the AI boom, and this transaction will add further dilution. Yet analysts at Cantor Fitzgerald and Needham have both reaffirmed their positive ratings and kept a $40 price target, arguing that the strategic endorsement from Washington outweighs the share-count expansion. TD Cowen went further, naming D-Wave one of the three biggest winners of the broader $2 billion NIST distribution to nine quantum companies, alongside Rigetti Computing and GlobalFoundries.

The cash infusion comes at a critical time. D-Wave reported a net cash position of roughly $553 million, but the operational burn rate remains high — the first-quarter net loss of $18.4 million underscores that. The company’s recent $550 million acquisition of Quantum Circuits Inc., completed in the quarter, added gate-model capability alongside its existing annealing platform, but it also dragged the gross margin from 92.5% to 63.6% as integration costs and revenue recognition shifts took their toll.

Bookings Soar as an Insider Cashes Out

A bright spot that complicated the narrative: D-Wave posted record bookings of $33.4 million in the first quarter, including a $20 million system sale and a $10 million corporate agreement. That metric, however, stands in stark contrast to the revenue figure, reflecting a gap between orders and recognized sales that the company will need to close.

The bullish sentiment was tempered on May 20 when Chief People Officer Sophie Ames sold 23,025 shares through a pre-arranged 10b5-1 trading plan. While such sales are routine and pre-scheduled, they never improve the optics when a stock is on a tear.

Next Stops: Investor Day and a String of Conferences

The near-term calendar is dense. D-Wave’s investor day, themed "The D-Wave Difference," is set for June 1. Management will also appear at conferences hosted by TD Cowen on May 28, Baird on June 3, and Rosenblatt on June 10. These events will be the real test of whether the company can convince investors that the booking explosion will eventually translate into recognized revenue.

Analyst consensus remains broadly constructive. The average price target across 13 buy-rated analysts stands at $35.17, ranging from $19.58 to $45. No analyst rates the stock a sell. The final milestone that will crystallize the equity-for-funding deal is the execution of definitive grant documents. Only then will the actual share transfer to the Commerce Department occur, making the dilution concrete and measurable.

For now, D-Wave is playing a high-stakes game of quantum chess: Washington has taken a seat on the shareholder register, the booking pipeline is swelling, and the revenue line is in free fall. The next few weeks will determine whether the board reassembles into a winning position.